Peng Xia
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Liver physiology and pathology 8
- Co-authors
- Limeng ChenLubin XuHua ZhengLi WangYumo ZhaoDongli TianJing AiMeiyu Geng
- Journals
- European Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Medical Physics (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Acta Pharmacologica Sinica (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Peng Xia
105 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Nephrology 166
- Cancer Research 303
- Endocrinology, Diabetes and Metabolism 231
- Molecular Biology 902
- Hepatology 94
Countries citing papers authored by Peng Xia
This map shows the geographic impact of Peng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Xia more than expected).
Fields of papers citing papers by Peng Xia
This network shows the impact of papers produced by Peng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Xia. The network helps show where Peng Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 25 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 39 | |
| 16 | 2020 | 26 | |
| 17 | 2017 | 26 | |
| 18 | 2016 | 28 | |
| 19 | 2014 | 25 | |
| 20 | 2012 | 18 |
About Peng Xia
Peng Xia is a scholar working on Hepatology, Nephrology, Radiation, Cancer Research and Molecular Biology, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (9 papers), Liver physiology and pathology (8 papers), Advanced Radiotherapy Techniques (7 papers), Cancer-related gene regulation (7 papers), Kruppel-like factors research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Epigenetics and DNA Methylation (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Nephrology (166 citations), Cancer Research (303 citations), Endocrinology, Diabetes and Metabolism (231 citations), Molecular Biology (902 citations) and Hepatology (94 citations). Peng Xia has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Limeng Chen, Lubin Xu, Hua Zheng, Li Wang, Yumo Zhao, Dongli Tian, Jing Ai, Meiyu Geng, Chengxue Dang and Wei Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Medical Physics, International Journal of Radiation Oncology*Biology*Physics and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.